Vanda Pharmaceuticals (VNDA) Retained Earnings (2010 - 2026)
Vanda Pharmaceuticals (VNDA) reported Retained Earnings of $212000.0 for Q1 2026, down 44.65% on a YoY basis from $383000.0 in Q1 2025, and down 66.3% sequentially from $629000.0 in Q4 2025.
Vanda Pharmaceuticals (VNDA) Retained Earnings (2010 - 2026) Analysis & Trends
Vanda Pharmaceuticals (VNDA) has 17 years of Retained Earnings data on file, last reported at $212000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 44.65% year-over-year to $212000.0; the trailing twelve-month figure through Mar 2026 stood at $212000.0 (down 44.65% YoY), and the FY2025 full-year result was $629000.0, up 750.0% from the prior year.
- Retained Earnings declined to $212000.0 in Q1 2026, from $629000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $702000.0 in Q3 2024 to a low of -$170.6 million in Q1 2022.
- A 5-year average of -$38.0 million and a median of -$255000.0 in 2023 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings tumbled 88957.29% in 2022 and surged 750.0% in 2025, its largest moves.
- Tracing VNDA's Retained Earnings over 5 years: stood at -$1.2 million in 2022, then soared by 97.49% to -$30000.0 in 2023, then surged by 346.67% to $74000.0 in 2024, then surged by 750.0% to $629000.0 in 2025, then plunged by 66.3% to $212000.0 in 2026.
- Business Quant data shows VNDA's Retained Earnings at $212000.0 in Q1 2026, $629000.0 in Q4 2025, and $540000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn | 212,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 212,000.00 |
| Dec 31, 2025 | 629,000.00 |
| Sep 30, 2025 | 540,000.00 |
| Jun 30, 2025 | 396,000.00 |
| Mar 31, 2025 | 383,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Sep 30, 2024 | 702,000.00 |
| Jun 30, 2024 | -330,000.00 |
| Mar 31, 2024 | -383,000.00 |
| Dec 31, 2023 | -30,000.00 |
| Sep 30, 2023 | -152.99 Mn |
| Jun 30, 2023 | -153.13 Mn |
| Mar 31, 2023 | -255,000.00 |
| Dec 31, 2022 | -1.19 Mn |
| Sep 30, 2022 | -1.49 Mn |
| Jun 30, 2022 | -168.03 Mn |
| Mar 31, 2022 | -170.61 Mn |
| Dec 31, 2021 | -175,000.00 |
| Sep 30, 2021 | 111,000.00 |
| Jun 30, 2021 | -179.03 Mn |